PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY by O. V. Dralova, M. L. Maksimov

Get full text

Clinical efficiency of medium and high doses of valsartan in the treatment of patient with arterial hypertension and chronic kidney diseases by M L Maximov, O V Dralova

Get full text

RETRACTED: An objective: to lower blood pressure effectively and safely. How to do it in a rational and modern way? by O. V. Dralova, M. L. Maksimov

Get full text

Angiotensin II receptor antagonist valsartan in treatment of patients with arterial hypertension and chronic kidney diseases. Hypotensive and nephroprotective efficacy by M L Maximov, O V Dralova

Get full text

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application by M L Maksimov, O V Dralova

Get full text

COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH G... by O. V. Dralova, M. L. Maksimov

Get full text

Obesity: current approaches to adequate pharmacotherapy by M. L. Maksimov, S. S. Sologova, O. V. Dralova

Get full text

ADVANTAGES AND NOVELTY OF CLINICAL APPLICATION OF THE TRIPLE COMBINATION FOR ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA: ACE INHIBITOR PERINDOPRIL WITH ROSUVASTATIN AND INDAPAMIDE by M. L. Maksimov, A. S. Ermolaeva, O. V. Dralova

Get full text

Clinical application of direct renin inhibitor aliskiren in combined therapy of patients with arterial hypertension and metabolic syndrome by O V Dralova, M L Maximov, A S Ermolaeva

Get full text

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection by M. L. Maksimov, O. V. Dralova, A. K. Starodubtsev

Get full text

Olmesartan: vasoprotective effects and reducing the risk of vascular accidents by O. D. Ostroumova, M. L. Maksimov, O. V. Dralova, A. S. Yermolayeva

Get full text

Clinical efficacy of AT1-receptors of angiotensin II valsartan in the pharmacotherapy of patients with arterial hypertension and chronic heart failure by A K Starodubtsev, M L Maximov, O V Dralova, A S Ermolaeva

Get full text

THE PROBLEM OF OBESITY AND OVERWEIGHT IN THE RUSSIAN FEDERATION AND ITS PHARMACOECONOMIC ASSESSMENT by V. S. Krysanova, M. V. Zhuravleva, O. V. Dralova, O. A. Rogacheva, T. R. Kameneva

Get full text

Modern drugs for obesity and metabolic syndrome treatment (Review) by M. L. Maximov, O. V. Dralova, V. G. Kukes, V. N. Chubarev, V. V. Tarasov

Get full text